No Data
No Data
No Data
Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.
Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).
Kohjin Bio: March 2025 quarter 1 financial results announcement [Japan standard] (consolidated)
Skylark, Dentsu G, Ebara, Asahi Intec (14th)
*The above calendar is subject to change due to company circumstances. --------------------------------------- August 14th (Wed) <1380> Akikawa Bokuen <1443> GikenHD <147A> Solacom <1491> Chugai Mining <149A> Shinka <157A> Green Monster <160A> Az Partners <1711> SDSHD 1
Emerging markets outlook: be cautious of a one-step decline in the Growth Market 250 index, will continue to search for double-digit stocks by elimination method.
In the current market situation, there is strong selling pressure to avoid risks, and the emerging markets saw a significant decline this week. The rise and fall rates during this period showed that while the Nikkei average fell by -4.67%, the growth market index fell significantly further by -9.62%, and the growth market 250 index fell by -10.36%. Looking back as far as the former Mothers Index, this marked the lowest decline rate since the week of January 1, 2022, of -10.61%. Similar to the primary market, the strong selling pressure to avoid risk is due to factors such as the rapid appreciation of the yen after the meeting of the central banks of Japan, the US and China, and growing concern about a recession in the US economy.
Kohjin Bio To Go Ex-Dividend On March 28th, 2025 With 14 JPY Dividend Per Share
August 2nd (Japan Standard Time) - $Kohjin Bio(177A.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 14 JPY dividend per share. The ex-dividend
Kojin Bio [Lockup Release Schedule]
Cozyn Bio <177A> estimated release shares: 4,165,000 shares (estimated) Release date: July 25, 2024 If the stock price is 1.5 times or more from the public offering price after the listing date, there may be a possibility of selling. Target shareholders: Estimated shares SMBC Business Development No.1 Investment Business Limited Liability Partnership: 100,000 shares Saitama Resona Bank No.2 Investment Business Union: 100,000 shares Takahito Nakamura: 2
No Data